In our study we have observed that KRAS and NRAS mutations were frequent in high risk patients, Muhammad et al.48 showed, MDS patient with RAS gene mutation progressed to AML and its unfavorable indicator of survival in AML. This evidence concerns the gene NRAS and myelodysplastic syndrome.